Atea Pharmaceuticals, Inc.
Clinical trials sponsored by Atea Pharmaceuticals, Inc., explained in plain language.
-
New hep c pill combo takes on standard therapy in major trial
Disease control Recruiting nowThis study compares a new oral medication, Bemnifosbuvir-Ruzasvir, to the current standard treatment, Sofosbuvir-Velpatasvir, for adults with chronic hepatitis C. About 880 participants who have not taken similar drugs before will receive one of the two treatments. The main goal …
Phase: PHASE3 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug interaction study recruits healthy volunteers
Knowledge-focused Recruiting nowThis study looks at how a new drug combination (BEM/RZR) changes the way the body processes buprenorphine/naloxone or methadone, which are used for opiate withdrawal. It involves 32 healthy adults who are on stable doses of these medications. The goal is to measure drug levels in…
Phase: PHASE1 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 09:43 UTC
-
New study checks drug safety in patients with kidney or liver failure
Knowledge-focused Recruiting nowThis study looks at how a single dose of the experimental drug combination bemnifosbuvir/ruzasvir behaves in people with severe kidney or liver problems compared to healthy people. About 28 adults will take one dose and have their blood tested to measure drug levels and safety. T…
Phase: PHASE1 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 09:30 UTC